https://t.co/NmFc5Mnp4T 4D CT is superior to ultrasound and sestamibi for localising recurrent parathyroid disease
When they work out how to reduce the dose of radiation required, they could supervise MIBI for initial localisation.
RT @mavgpro: Además, es una herramienta útil en el diagnóstico diferencial del adenoma paratiroideo con los ganglios linfáticos y con l…
Approach to recurrent #hyperparathyroidism is a team work since localisation of hyperfunctioning #parathyroid gland(s) is even more crucial than before first intervention! #nuclearmedicine and #radiology with neck MRI must help #endocrinologists and super
#endowitter @AKUGlobal
Además, es una herramienta útil en el diagnóstico diferencial del adenoma paratiroideo con los ganglios linfáticos y con los islotes de tejido tiroideo extracapsular, en pacientes con #hiperparatiroidismoprimario
4D-CT scans are more sensitive than sestamibi scans or ultrasound for tumor localization in recurrent parathyroid disease. #JAM2019 #CheckYourCalcium @ParaTroupers1 @TheAACE @TheEndoSociety Find more info at https://t.co/98iDiXNzO9 and https://t.co/COmLP
First I've heard this could be recurrent in some people. Now that's quite depressing! https://t.co/Fr6R9fLO4d
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
RT @AnnSurgOncol: MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvR…
MAY ISSUE: #4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #ParathyroidDisease. https://t.co/trvRIxGjC1 https://t.co/5B7vgQ6L9k
RT @michaelyehmd: 4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #Parathyroid Disease. Nice work @MatthewNehsMD @At…
RT @RLSlotcavageMD: This is our preferred technique as well! https://t.co/hWY39iGLvc
This is our preferred technique as well! https://t.co/hWY39iGLvc
RT @michaelyehmd: 4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #Parathyroid Disease. Nice work @MatthewNehsMD @At…
Totally agreed, but most https://t.co/RVYlNh0iD0 do not approve despite MD appeal calls. We need to change their “blueprint” https://t.co/ryONo2wgKA
RT @michaelyehmd: 4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #Parathyroid Disease. Nice work @MatthewNehsMD @At…
RT @michaelyehmd: 4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #Parathyroid Disease. Nice work @MatthewNehsMD @At…
4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent #Parathyroid Disease. Nice work @MatthewNehsMD @Atul_Gawande @gmdoherty #hyperparathyroidism https://t.co/LPtmQkc13F https://t.co/dB78tPOOJO